Melatonin Bluefish

Melatonin, the active ingredient in Melatonin Bluefish, is a melatonin receptor agonist presented as an oral supplement for oral use. It helps regulate the sleep‑wake cycle and is primarily used as a sleep aid in adults. GNH USA supplies Melatonin Bluefish as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin acts on the melatonin receptor pathway to support circadian rhythm regulation.

Insomnia: assists in initiating sleep and improving overall sleep quality in adults. Jet lag: helps synchronize the internal clock after rapid travel across time zones. Shift work disorder: supports adjustment of sleep timing for individuals working irregular hours.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Dizziness - Nausea - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Allergic reaction such as rash, swelling, or itching - Severe hypersensitivity (anaphylaxis) - Mood changes including depression or irritability - Significant hypotension in susceptible individuals

Consider the following precautions before using Melatonin Bluefish. - Pregnancy: safety not established; consult a healthcare professional before use. - Breastfeeding: unknown safety profile; weigh potential benefits against risks. - Concomitant CNS depressants: may increase sedation and impair alertness. - Underlying sleep disorders: evaluate the cause of insomnia before initiating therapy. - Elderly: start with the lowest effective dose and monitor for confusion or excessive drowsiness. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Melatonin may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): may reduce immunosuppressive efficacy.

Moderate Interactions (Monitor Closely): - CNS depressants (benzodiazepines, alcohol): enhanced drowsiness. - Antidepressants (SSRIs, SNRIs): possible modulation of serotonin pathways. - Antihypertensives: additive blood‑pressure‑lowering effect.